GRAIL, LLC (GRAL) - Total Assets
Based on the latest financial reports, GRAIL, LLC (GRAL) holds total assets worth $2.80 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore GRAIL, LLC debt service capacity to assess how comfortably operating cash covers total debt obligations.
GRAIL, LLC - Total Assets Trend (2018–2025)
This chart illustrates how GRAIL, LLC's total assets have evolved over time, based on quarterly financial data. See GRAL net asset value for net asset value and shareholders' equity analysis.
GRAIL, LLC - Asset Composition Analysis
Current Asset Composition (December 2025)
GRAIL, LLC's total assets of $2.80 Billion consist of 32.6% current assets and 67.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.6% |
| Accounts Receivable | $18.30 Million | 0.6% |
| Inventory | $16.02 Million | 0.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.85 Billion | 63.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how GRAIL, LLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see GRAL market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: GRAIL, LLC's current assets represent 32.6% of total assets in 2025, a decrease from 94.5% in 2018.
- Cash Position: Cash and equivalents constituted 8.6% of total assets in 2025, down from 13.9% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 63.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is intangible assets at 63.3% of total assets.
GRAIL, LLC Competitors by Total Assets
Key competitors of GRAIL, LLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fleury S.A.
SA:FLRY3
|
Brazil | R$13.33 Billion |
|
Cowealth Medical China Co.Ltd.
SHG:603122
|
China | CN¥1.41 Billion |
|
Spectral Med Inc
TO:EDT
|
Canada | CA$8.12 Million |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
INTERGRATED DIA.H DL 025
F:8I8
|
Germany | €6.77 Billion |
|
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193
|
China | CN¥984.02 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
|
SCOPE FLUIDICS SA ZY-10
F:S84
|
Germany | €195.94 Million |
GRAIL, LLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 11.74 | 9.71 | 10.53 |
| Quick Ratio | 11.51 | 9.46 | 10.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $802.64 Million | $652.68 Million | $578.37 Million |
GRAIL, LLC - Advanced Valuation Insights
This section examines the relationship between GRAIL, LLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.01 |
| Latest Market Cap to Assets Ratio | 0.88 |
| Asset Growth Rate (YoY) | -2.1% |
| Total Assets | $2.92 Billion |
| Market Capitalization | $2.58 Billion USD |
Valuation Analysis
Near Book Valuation: The market values GRAIL, LLC's assets close to their book value (0.88x), suggesting investors view the company's assets at approximately fair value.
Slight Asset Contraction: GRAIL, LLC's assets decreased by 2.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for GRAIL, LLC (2018–2025)
The table below shows the annual total assets of GRAIL, LLC from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $2.92 Billion | -2.05% |
| 2024-12-31 | $2.98 Billion | -34.53% |
| 2023-12-31 | $4.56 Billion | -18.66% |
| 2022-12-31 | $5.60 Billion | -42.47% |
| 2021-12-31 | $9.74 Billion | +1278.73% |
| 2020-12-31 | $706.30 Million | +11.14% |
| 2019-12-31 | $635.52 Million | -7.47% |
| 2018-12-31 | $686.85 Million | -- |
About GRAIL, LLC
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides deve… Read more